Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Slides:

Advertisements

Similar presentations

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Advertisements

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Reply The Annals of Thoracic Surgery

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Joshua E. Rosen, BASc, Hari B

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M

Armin Kiankhooy, MD, Matthew D. Taylor, MD, Damien J

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Feasibility and Safety of Nonintubated Thoracoscopic Lobectomy for Geriatric Lung Cancer Patients Chun-Yu Wu, MD, Jin-Shing Chen, MD, PhD, Yi-Shiuan.

Robot-Assisted Lobectomy for Early-Stage Lung Cancer: Report of 100 Consecutive Cases Farid Gharagozloo, MD, Marc Margolis, MD, Barbara Tempesta, MS,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Loretta Erhunmwunsee, MD, Brian C

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy Basil S. Nasir, MBBCh, Ayesha.

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer Pamela Samson, MD, MPHS, Traves.

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Effects of Blood Transfusion on Cause-Specific Late Mortality After Coronary Artery Bypass Grafting—Less Is More Thomas A. Schwann, MD, Joseph R. Habib,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Changes in Pulmonary Function in Lung Cancer Patients After Video-Assisted Thoracic Surgery Se Joong Kim, MD, PhD, Yeon Joo Lee, MD, Jong Sun Park, MD,

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection Mark K. Ferguson, MD, Megan Huisingh-Scheetz, MD, MPH, Katherine.

Specialty Training and Mortality After Esophageal Cancer Resection

Sebastien Gilbert, MD, Sonam Maghera, BS, Andrew J

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Yinin Hu, MD, Timothy L. McMurry, PhD, Kristen M. Wells, PhD, James M

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J. Urbanic, MD, Andrew B. Sharabi, MD, PhD, Samir Gupta, MD, Megan E. Daly, MD, James D. Murphy, MD, MS The Annals of Thoracic Surgery Volume 105, Issue 2, Pages 425-431 (February 2018) DOI: 10.1016/j.athoracsur.2017.07.048 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Inclusion and exclusion criteria. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery 2018 105, 425-431DOI: (10.1016/j.athoracsur.2017.07.048) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Cumulative incidence of cancer-specific death for stereotactic body radiation therapy (SBRT [red line]), sublobar resection (gray line), and lobectomy (blue line). The Annals of Thoracic Surgery 2018 105, 425-431DOI: (10.1016/j.athoracsur.2017.07.048) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Forest plots illustrating the effects of treatment on different subgroups of patients with stage I non-small cell lung cancer. The plot represents the results of multivariable Fine-Gray regressions to evaluate the risk of cancer-related death for stereotactic body radiation therapy (SBRT) versus lobectomy (left plot) and SBRT versus sublobar resection (right plot). The p values represent an interaction term in the model. (CI = confidence interval; FEV1 = forced expiratory volume in 1 second.) The Annals of Thoracic Surgery 2018 105, 425-431DOI: (10.1016/j.athoracsur.2017.07.048) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions